Interferon Blocker Crushes Macrophage Activation Syndrome

(MedPage Today) -- In a small prospective trial, a common complication of systemic juvenile idiopathic arthritis (sJIA) and its adult-onset counterpart were quickly brought under control with emapalumab (Gamifant), an inhibitor of interferon-gamma...
Source: MedPage Today Pediatrics - Category: Pediatrics Source Type: news